LIANLO AS
Operating
Utvikling av utstyr og tilhørende reagenser for bruk innen forskning,
utvikling og diagnostikk, oppdragsforskning, laboratorietjenester,
konsulenttjenester, samt utleie av lokaler og utstyr.
Bioteknologi hvor man utvikler utstyr og tilhørende reagenser for bruk
innen forskning, utvikling og diagnostikk. Det vil i noen tilfeller
utføres oppdragsforskning for andre og konsulentvirksomhet knyttet til
bioteknologibransjen. Det vil også være andre aktører som kan leie
utstyr og laboratorieplass hos selskapet.
Organization
- CEO
- RL
Roger Løvlie1971
- Chairman of the board
- RL
Roger Løvlie1971
- Years since formation
- 4 years
- since Jan 4, 2022
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 457,054
- NOK
- Annual total result 2025
- -185,668
- NOK
- Total equity 2025
- 1,109,091
- NOK
Last update: Jun 11, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
RL 1971 | Managing Director/CEO | 100 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
RL 1971 | Chairman | 100 % indirectly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
RL 1971 | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -8,848Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 457,054 | 1,096,714 | 1,223,471 | 1,653,814 | 0 |
Annual Total Result | -185,668 | 268,360 | 200,103 | 801,865 | 0 |
Total assets | 1,147,782 | 1,453,445 | 1,146,030 | 1,245,514 | 30,000 |
Total liabilities | 38,691 | 158,686 | 119,631 | 419,218 | 0 |
Total equity | 1,109,091 | 1,294,758 | 1,026,399 | 826,295 | 30,000 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 457,054 | 1,096,714 | 1,223,471 | 1,653,814 | 0 |
Total operating costs | 677,496 | 792,405 | 1,002,139 | 607,109 | 0 |
Operating result | -220,442 | 304,310 | 221,333 | 1,046,705 | 0 |
Financial income/costs | 34,827 | 39,741 | 35,998 | -20,244 | 0 |
Profit before tax | -185,616 | 344,051 | 257,330 | 1,026,461 | 0 |
Total tax & extraordinary income/cost | 52 | 75,691 | 57,227 | 224,596 | 0 |
Annual Total Result | -185,668 | 268,360 | 200,103 | 801,865 | 0 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 33,673 | 0 | 0 | 0 | 0 |
Total current assets | 1,114,109 | 1,453,445 | 1,146,030 | 1,245,514 | 30,000 |
Total assets | 1,147,782 | 1,453,445 | 1,146,030 | 1,245,514 | 30,000 |
Short term debt | 35,197 | 127,998 | 115,501 | 403,531 | 0 |
Long term debt | 0 | 30,689 | 4,131 | 15,687 | 0 |
Total liabilities | 38,691 | 158,686 | 119,631 | 419,218 | 0 |
Contributed capital | 24,430 | 24,430 | 24,430 | 24,430 | 30,000 |
Retained earnings | 1,084,661 | 1,270,328 | 1,001,969 | 801,865 | 0 |
Total equity | 1,109,091 | 1,294,758 | 1,026,399 | 826,295 | 30,000 |
Total equity and liabilities | 1,147,782 | 1,453,444 | 1,146,030 | 1,245,513 | 30,000 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises